Position in IONS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,264,705
-$952,796 QoQ
Shares Held
110,064
-5.5% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
4.86%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Exome Asset Management LLC holds $121,183,293 across 31 Biotechnology names. IONS ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
45,469 | $14,649,657 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
278,533 | $10,720,735 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
220,091 | $8,627,567 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
This page
|
110,064 | $8,264,705 | |
| 5 | CYTK |
Cytokinetics Inc
|
103,718 | $6,836,053 | |
| 6 | ALMS |
Alumis Inc.
|
279,176 | $6,150,247 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
67,492 | $5,011,955 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
114,991 | $4,626,087 |
All Filings in IONS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,264,705 | 110,064 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,217,501 | 116,515 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,571,066 | 131,016 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,785,293 | 121,116 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $4,091,534 | 135,616 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,145,390 | 61,367 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||